I should also point out that the FDA has been exceedingly aggressive in their support for the complex molecule approval framework that MNTA essentially proposed/designed. I would not be surprised to see them approve Copaxone in the near future.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.